Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Neoplasms 6Lung Neoplasms 5Glioblastoma 4Urinary Bladder Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Breast Neoplasms 3Brain Neoplasms 3Pancreatic Neoplasms 2Lung Diseases 2Glioma 2Astrocytoma 2Uterine Cervical Neoplasms 1Tuberculosis, Pulmonary 1Thyroid Nodule 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Pleural Neoplasms 1Pancreatic Cyst 1Oropharyngeal Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Pulmonary Nodules 1Mouth Neoplasms 1Mesothelioma 1Medication Adherence 1

Interventions

Sorafenib 222lenvatinib 147Bevacizumab 131Nivolumab 87atezolizumab 81pembrolizumab 74Radiosurgery 71durvalumab 63sintilimab 61Oxaliplatin 60Fluorouracil 56Doxorubicin 47tislelizumab 46apatinib 45Radiofrequency Ablation 44Hepatectomy 43camrelizumab 41Leucovorin 41Radiotherapy 40tremelimumab 37Magnetic Resonance Spectroscopy 36regorafenib 34Capecitabine 30Immune Checkpoint Inhibitors 29Folfox protocol 29Cisplatin 28cabozantinib 26Gemcitabine 26Cyclophosphamide 26Ipilimumab 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Drug Delivery Systems × Clear all
NCT05903456 2023-06-15

Icaritin Soft Capsule Combined With Lenvatinib and TACE for the Treatment of Hepatocellular Carcinoma

Zhejiang Cancer Hospital

Phase 2 Unknown
20 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02828865 2020-07-07

A Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers

National Taiwan University Hospital

Phase NA Completed
18 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT01078415 2016-11-08

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Angiodynamics, Inc.

Phase NA Completed
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡